Claudine Bernard-Henry

A highly virulent variant of HIV-1 circulating in the Netherlands

Chris Wymant, Daniela Bezemer, François Blanquart et al. · Science · 2022 · 75 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +14

Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial

P. Mercié, Julie Arsandaux, Christine Katlama et al. · The Lancet HIV · 2018 · 66 citations

Public Health, Pharmacology, Pharmacotherapy +10

Efavirenz as a Substitute for Protease Inhibitors in HIV-1–Infected Patients With Undetectable Plasma Viral Load on HAART: A Median Follow-Up of 64 Weeks

David Rey, Marie‐Paule Schmitt, Marialuisa Partisani et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2001 · 23 citations

Medicine, Pharmacology, Pharmacotherapy +17

Bone mineral density changes after 2 years of ARV treatment, compared to naive HIV-1-infected patients not on HAART

David Rey, Michèle Treger, Jean Sibilia et al. · Infectious Diseases · 2014 · 18 citations

Medicine, Infectious Diseases, Bone Metabolism +15

Reaching the Second and Third Joint United Nations Programme on Human Immunodeficiency Virus (HIV)/AIDS 90-90-90 Targets Is Accompanied by a Dramatic Reduction in Primary HIV Infection and in Recent HIV Infections in a Large French Nationwide HIV Cohort

Adrien Le Guillou, Pascal Puglièse, F. Raffi et al. · Clinical Infectious Diseases · 2019 · 17 citations

Public Health, Health Sciences, Infectious Diseases +13